SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN ISSUER
PURSUANT
TO RULE 13a-16 OR 15b-16 OF
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of March, 2025
Cresud
Sociedad Anónima, Comercial,
Inmobiliaria,
Financiera y
Agropecuaria
(Exact name of Registrant as specified in its
charter)
Cresud Inc.
(Translation of registrant´s name into
English)
Republic
of Argentina
(Jurisdiction of incorporation or organization)
Carlos
Della Paolera 261
(C1001ADA)
Buenos
Aires, Argentina
(Address of principal
executive offices)
Form 20-F ⌧ Form
40-F ☐
Indicate by
check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information
to the Commission pursuant to Rule 12g3-2(b) under the Securities
Exchange Act of 1934.
Yes o No
x
CRESUD
S.A.C.I.F. and A.
(THE
“COMPANY”)
REPORT
ON FORM 6-K
Attached is an
English translation of the letter dated March 6, 2025, filed by the
Company with the Bolsa de Comercio de Buenos Aires and the
Comisión Nacional de Valores.
Buenos Aires,
Argentina – March 6, 2025 – Cresud Sociedad
Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria
(the “Company”) (NASDAQ: CRESY,
BYMA:CRES), informs
that between February 17 and 25, 2025, certain warrants holders
have exercised their right to acquire additional shares.
Therefore, a total of 1,908,747 ordinary shares of the Company will be registered,
with a face value of ARS 1. As a result of the exercise, USD
767,125 were collected by the
Company.
After the exercise of these warrants, the number of shares and the
capital stock of the Company increased
from
603,140,435
to 605,049,182, and the number of outstanding warrants
decreased from
81,063,170
to
79,706,994.
The
following table provides a summary of the information regarding the
options and shares issued by the Company:
Ordinary
shares prior to Feb-2025 exercise
|
603,140,435
|
Warrants
exercised in Feb-2025
|
1,356,176
|
Current
Ratio (ordinary shares of face value of ARS 1 per
warrant)
|
1.4075
|
Current
exercise price (per ordinary share of face value of ARS
1)
|
USD
0.4019
|
Shares
issued for Feb-2025 exercise*
|
1,908,747
|
|
|
Outstanding
Warrants after Feb-2025 exercise
|
79,706,994
|
Shares
to be issued upon warrant exercise
|
112,187,594
|
|
|
Outstanding
ordinary shares after Nov-2024 exercise
|
605,049,182
|
Fully
Diluted
|
717,236,776
|
*The
amount includes rounding adjustments for each exercise instruction
calculation.